ArticleDrug safety2021

Comment on: Frequency and Associated Costs of Anaphylaxis- and Hypersensitivity-Related Adverse Events for Intravenous Iron Products in the USA: An Analysis Using the US Food and Drug Administration Adverse Event Reporting System.

Michael AuerbachPubMed ↗Publisher ↗

No numbers read from the abstract.